Target intelligence / Profile preview

Memory T cell adoptive transfer

Molecular classification
Other (cell population), T lymphocyte subset, Immune cell subset
01

Overview

Memory T cell adoptive transfer is a therapeutic technique in which antigen-experienced T cell subsets, primarily central memory (T_CM) and effector memory (T_EM) T cells, are isolated, sometimes genetically engineered or expanded ex vivo, and then infused into patients to reconstitute or enhance immune responses against infections and malignancies. These memory T cells are distinguished by their long-term persistence, self-renewal, rapid recall upon antigen re-exposure, and specialized trafficking properties, contributing to effective immune surveillance and lasting protection. Clinical efficacy depends heavily on the subset composition, with central memory T cells showing superior persistence and expansion capacity compared to effector memory T cells, making them preferred candidates for adoptive immunotherapy[1][2][3][4][5][7].

Other names
Memory T cellscentral memory T cells (T_CM)effector memory T cells (T_EM)memory stem T cellstissue-resident memory T cellsmemory T lymphocytes
02

Mechanism of action

Adoptive transfer provides long-lived immunity via engraftment and persistence of transferred memory T cells. Expansion, trafficking, and immune protection against target antigens (infectious or malignant). Some protocols genetically engineer T cells to direct antigen targeting (CAR-T, modified TCR).

03

Biological functions

Immune responseImmunological memoryCell proliferationAntigen recognitionTumor surveillanceInfection protection
04

Disease associations

CancerInfectionImmunodeficiency
05

Safety considerations

Risk of graft-versus-host disease with allogeneic cell sourcesPoor survival/persistence of terminally differentiated cells vs. central memory cellsT cell exhaustion; suppression by regulatory T cellsOverstimulation, cytokine release syndrome (in expanded/engineered T cells)
06

Interacting drugs

Specific immune cell therapies using memory T cell subsets

2 more in the full profile.

07

Biomarkers

Cell surface markers: CD62L, CCR7, CD28, CD127 for central memory T cellsTracking efficacy: persistence of transferred cells; immune reconstitution in blood/tissueExpression levels of exhaustion markers (e.g., PD1, LAG3) in transferred T cell populations (tumor context)

Beyond the preview

Go deeper on Memory T cell adoptive transfer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memory T cell adoptive transfer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call